Accessibility Menu
Organigram Global logo

Organigram Global

(TSX) OGI

Current PriceCA$1.52
Market CapCA$207.43M
Since IPO (2014)-82%
5 Year-90%
1 Year-24%
1 Month-1%

Organigram Global Financials at a Glance

Market Cap

CA$207.43M

Revenue (TTM)

CA$274.19M

Net Income (TTM)

-CA$25.21M

EPS (TTM)

-CA$0.19

P/E Ratio

-8.04

Dividend

CA$0.00

Beta (Volatility)

1.86 (High)

Price

CA$1.52

Volume

55,228

Open

CA$1.48

Previous Close

CA$1.52

Daily Range

CA$1.46 - CA$1.52

52-Week Range

CA$1.44 - CA$3.09

Estimated Earnings Date

Aug 12, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organigram Global

Industry

Pharmaceuticals

Employees

1,139

CEO

James Hideo Yamanaka, MBA

Headquarters

Moncton, NB E1E 3X3, CA

OGI Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-39%

Net Income Margin

-9%

Return on Equity

-7%

Return on Capital

-24%

Return on Assets

-5%

Earnings Yield

-12.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$207.43M

Shares Outstanding

136.47M

Volume

55.23K

Avg. Volume

181.36K

Financials (TTM)

Gross Profit

CA$9.51M

Operating Income

-CA$88.31M

EBITDA

-CA$20.55M

Operating Cash Flow

-CA$7.59M

Capital Expenditure

-CA$17.05M

Free Cash Flow

-CA$24.64M

Cash & ST Invst.

CA$84.42M

Total Debt

CA$8.75M

Organigram Global Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$59.79M

-8.9%

Gross Profit

-CA$9.01M

-148.9%

Gross Margin

-15.06%

N/A

Market Cap

CA$207.43M

N/A

Market Cap/Employee

CA$189.78K

N/A

Employees

1,093

N/A

Net Income

-CA$921.00K

-102.2%

EBITDA

-CA$28.01M

-920.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$54.75M

+289.6%

Total Debt

CA$8.20M

-14.0%

Accounts Receivable

CA$53.39M

+6.8%

Inventory

CA$135.16M

+17.5%

Long Term Debt

CA$7.24M

-12.0%

Short Term Debt

CA$957.00K

-26.7%

Return on Assets

-4.84%

N/A

Return on Invested Capital

-24.48%

N/A

Free Cash Flow

-CA$6.53M

+71.8%

Operating Cash Flow

-CA$6.30M

+62.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XLY.TOAuxly Cannabis Group Inc.
CA$0.16-0.00%
ACB.TOAurora Cannabis Inc.
CA$4.28-6.75%
WEED.TOCanopy Growth Corporation
CA$1.42-0.70%
HLS.TOHLS Therapeutics Inc.
CA$4.45+2.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$116.96+0.09%
AALAmerican Airlines Group
$14.65+0.09%
SPCEVirgin Galactic
$5.73+0.22%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.83-0.10%

Questions About OGI

What is the current price of Organigram Global?

Organigram Global is trading at CA$1.52 per share.

What is the 52-week range for Organigram Global?

Over the past 52 weeks, Organigram Global has traded between CA$1.44 and CA$3.09.

How much debt does Organigram Global have?

As of the most recent reporting period, Organigram Global reported total debt of CA$8.20M.

How much cash does Organigram Global have on hand?

Organigram Global reported CA$53.94M in cash and cash equivalents in its most recent financial results.

What is Organigram Global’s dividend yield?

Organigram Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.